Altimmune, Inc

(NASDAQ:ALT)

Latest On Altimmune, Inc (ALT):

Date/Time Type Description Signal Details
2023-05-11 16:23 ESTNewsAltimmune GAAP EPS of -$0.40 beats by $0.08N/A
2023-05-11 16:22 ESTNewsAltimmune, Inc. (ALT) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 12:33 ESTNewsAltimmune: A Story, It Seems, Of Too Little Too LateN/A
2023-03-22 23:18 ESTNewsAltimmune hits 10-month low as Goldman Sachs downgrades on weight loss dataN/A
2023-03-21 16:21 ESTNewsAltimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutideN/A
2023-03-21 16:20 ESTNewsAltimmune leads obesity drug developers lower after data for lead assetN/A
2023-02-28 16:09 ESTNewsAltimmune GAAP EPS of -$0.43 beats by $0.11N/A
2023-02-28 16:07 ESTNewsAltimmune (ALT) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:16 ESTNewsAltimmune Q4 2022 Earnings PreviewN/A
2023-02-23 11:31 ESTNewsAltimmune's Peptide-Based Therapies Offer Substantial OpportunityN/A
2023-02-21 21:15 ESTNewsAltimmune: Potential Dual Action For Pemvidutide In Obesity, NASHN/A
2022-12-21 01:07 ESTNewsAltimmune rises 5% on positive data from phase 1 trial of Non-Alcoholic Fatty Liver Disease treatmentN/A
2022-12-02 18:36 ESTNewsAltimmune Appears To Have A Winner, But Will The Market Believe?N/A
2022-12-02 01:08 ESTNewsAltimmune spikes as Goldman Sachs sees over 100% upsideN/A
2022-11-30 13:10 ESTNewsAltimmune: Weight Loss Data Signals A Costly ConfusionN/A
2022-11-11 05:50 ESTNewsAltimmune, Inc. (ALT) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 12:39 ESTNewsAltimmune GAAP EPS of -$0.48 beats by $0.01N/A
2022-11-10 12:38 ESTNewsAltimmune rises 5.2% on smaller-than-expected Q3 lossN/A
2022-09-16 22:56 ESTNewsAltimmune defended at H.C. Wainwright ahead of key readout for obesity drugN/A
2022-09-15 11:25 ESTNewsAltimmune: Overreaction On NASH Data Creates Buying OpportunityN/A
2022-09-14 18:07 ESTNewsAltimmune stock slumps 56% despite drug meeting main goal of reducing liver fat in trialN/A
2022-09-14 18:07 ESTNewsPiper Sandler sees Altimmune liver/obesity drug competitive despite weight loss dataN/A
2022-09-07 13:52 ESTNewsReassessing AltimmuneN/A
2022-09-01 01:36 ESTNewsAltimmune sets new 52-week high on rising volumeN/A
2022-08-11 22:36 ESTNewsAltimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8KN/A
2022-08-11 22:36 ESTNewsAltimmune quarterly net loss narrows as it beats on the bottom lineN/A
2022-08-11 22:36 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 05:48 ESTNewsAltimmune Q2 2022 Earnings PreviewN/A
2022-06-29 11:28 ESTNewsAltimmune: Several Catalysts In 2 Large Market Indications This YearN/A
2022-05-13 06:49 ESTNewsAltimmune, Inc. (ALT) CEO Vipin K. Garg on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 12:17 ESTNewsAltimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85MN/A
2022-05-11 18:31 ESTNewsAltimmune Q1 2022 Earnings PreviewN/A
2022-04-07 19:53 ESTNewsAltimmune's New Avatar As A Liver Disease PlayerN/A
2022-04-01 18:50 ESTNewsAltimmune begins enrollment in phase 2 trial of pemvidutide to treat obesityN/A
2022-03-15 16:28 ESTNewsAltimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19MN/A
2022-03-15 16:28 ESTNewsAltimmune stock falls ~5% despite Q4 beatN/A
2022-03-15 16:28 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-31 13:06 ESTNewsFDA clears Altimmune's pemvidutide application for obesityN/A
2022-01-03 16:07 ESTNewsAltimmune: Changing Focus To Pemvidutide In 2022N/A
2021-12-13 14:56 ESTNewsNew finance chief at AltimmuneN/A
2021-11-23 16:46 ESTNewsWarning: ALT is at high risk of performing badlyN/A
2021-11-22 18:32 ESTNewsAltimmune (ALT) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-11 20:59 ESTNewsAltimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-11 00:44 ESTNewsAltimmune EPS misses by $0.38, beats on revenueN/A
2021-11-11 00:43 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 02:01 ESTNewsAltimmune Q3 2021 Earnings PreviewN/A
2021-10-16 20:22 ESTNewsAltimmune: Changing The ThesisN/A
2021-10-04 22:54 ESTNewsAltimmune initiates Phase 1b trial of pemvidutide in non-alcoholic fatty liver diseaseN/A
2021-09-28 11:25 ESTNewsAltimmune spikes on data readout for obesity therapy tomorrowN/A
2021-09-28 11:25 ESTNewsAltimmune slips after posting 12-week data from Phase 1 trial for weight loss therapyN/A

About Altimmune, Inc (ALT):

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.

ALT Quotes by TradingView

See Advanced Chart

General

  • Name Altimmune, Inc
  • Symbol ALT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Last Split Factor1:30
  • Last Split Date2018-09-14
  • Fiscal Year EndDecember
  • IPO Date2005-10-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://altimmune.com
View More

Valuation

  • Trailing PE 1.82
  • Price/Sales (Trailing 12 Mt.) 54.44
  • Price/Book (Most Recent Quarter) 2.86
  • Enterprise Value Revenue 52.73
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.04
  • Next Year EPS Estimate $0.70
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -471%
  • Return on Assets -16%
  • Return on Equity -36%
  • Revenue 8.19 million
  • Earnings Per Share -$4.16
  • Revenue Per Share $0.32
  • Gross Profit -25324291
  • Quarterly Earnings Growth 301.7%
View More

Highlights

  • Market Capitalization 641.59 million
  • EBITDA -11790191
  • Analyst Target Price $41.83
  • Book Value Per Share $6.11
View More

Share Statistics

  • Shares Outstanding 37.15 million
  • Shares Float 29.2 million
  • % Held by Insiders 651%
  • % Held by Institutions 67.3%
  • Shares Short 2.41 million
  • Shares Short Prior Month 2.52 million
  • Short Ratio 1.22
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.37
  • 52 Week High $35.1
  • 52 Week Low $2.68
  • 50 Day Moving Average 17.82
  • 200 Day Moving Average 13.78
View More

Dividends

  • Dividend Date 2018-09-14
  • ExDividend Date 2017-01-20
  • Dividend Yield 0%
View More

Altimmune, Inc (ALT) Dividend Calendar:

ALT's last dividend payment was made to shareholders on September 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Altimmune, Inc (ALT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$2.31 million-$0.17-$0.8078.84%
2020-09-302020-11-09$2.94 million-$0.54-$0.7628.95%
2020-06-302020-08-11$N/A-$0.94-$0.29-229.82%
2020-03-312020-05-13$2.21 million-$0.26-$0.3218.75%
2019-12-312020-03-27$N/A-$0.25-$0.263.85%
2019-09-302019-11-13$643978-$0.74-$0.19-289.47%
2019-06-302019-08-13$1.63 million-$0.26-$0.25-4%
2019-03-312019-04-01$2.96 million-$0.27-$2.8090.36%
2018-12-312019-03-31$2.59 million-$2.34-$2.8016.43%
2018-09-302018-11-13$2.63 million-$1.73-$3.6051.94%
2018-06-302018-08-14$2.42 million-$10.20-$4.50-126.67%
2018-03-312018-05-15$2.69 million-$8.73-$15.0041.78%
2017-12-312018-03-28$2.3 million-$2.40-$15.0084%
2017-09-302017-11-09$4.59 million-$10.20-$8.40-21.43%
2017-06-302017-08-10$3.04 million-$7.73
2014-09-302014-11-06$962451-$24.00-$7.50-220%
2014-06-302014-08-04$3.66 million-$3.00-$16.5081.82%
2014-03-312014-05-08$3.74 million-$12.00-$18.0033.33%
2013-12-312014-03-11$3.65 million-$24.00-$15.00-60%
2013-09-302013-11-07$3.49 million-$24.00-$10.50-128.57%
2013-06-302013-08-07$4.3 million-$6.00-$9.0033.33%
2013-03-312013-05-08$6.48 million-$12.00-$15.0020%
2012-12-312013-03-13$6.01 million-$6.00-$12.0050%
2012-09-302012-11-06$6.7 million-$1.33-$9.0085.25%
2012-06-302012-08-07$6.32 million-$6.00-$9.0033.33%
2012-03-312012-05-08$6.15 million-$18.00-$15.00-20%
2011-12-312012-03-08$3.00-$32.00109.38%
2011-09-302011-11-09$5.26 million-$0.21-$25.0099.17%
2011-06-302011-08-10$6.43 million-$15.00-$31.5052.38%
2011-03-312011-05-11-$12.00-$29.0058.62%
2010-12-312011-03-28-$138.00-$26.00-430.77%
2010-09-302010-11-11-$42.00-$52.0019.23%
2010-06-302010-08-12-$66.00-$61.50-7.32%
2010-03-312010-05-11-$84.00-$51.00-64.71%
2009-12-312010-03-23-$60.00-$61.502.44%
2009-09-302009-11-12-$150.00-$57.00-163.16%
2009-06-302009-08-13-$72.00-$54.00-33.33%
2009-03-312009-05-15-$69.00-$60.00-15%
2008-12-312009-03-30-$51.00-$78.0034.62%
2008-09-302008-11-13-$60.00-$78.0023.08%
2008-06-302008-08-13-$296.82
2008-03-312008-05-14-$68.15
2007-09-302007-11-13-$20.56
2007-03-312007-03-31$7.48
2006-12-312006-12-31-$11,895.61
2006-09-302006-09-30$6.64
2006-06-302006-06-30$6.11
2006-03-312006-03-31$4.47
2005-12-312005-12-31$4.81

Altimmune, Inc (ALT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Altimmune, Inc (ALT) Chart:

ALT chart by TradingView

Altimmune, Inc (ALT) News:

Below you will find a list of latest news for Altimmune, Inc (ALT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Altimmune, Inc (ALT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-150.52.65CALL9 180TRUE-0.06-0.02
2026-05-1512.17CALL0 421225.34TRUE00
2026-05-151.51.49CALL2 23782.08TRUE-0.18-0.11
2026-05-1521.2CALL2 26573.27TRUE0.10.09
2026-05-152.50.58CALL1 1250TRUE-0.11-0.16
2026-05-1530.18CALL186 1000140.94TRUE0.030.2
2026-05-153.50.05CALL4 869169.81FALSE00
2026-05-1540.02CALL5 6584204.21FALSE-0.02-0.5
2026-05-154.50.05CALL0 5698.91FALSE00
2026-05-1550CALL0 310334.43FALSE00
2026-05-155.50CALL0 0739.24FALSE00
2026-05-1560CALL0 51423.24FALSE00
2026-05-156.50.09CALL0 2527.42FALSE00
2026-05-1570CALL0 5563.82FALSE00
2026-05-150.50PUT0 01207.71FALSE00
2026-05-1510.03PUT0 5754.75FALSE00
2026-05-151.50.03PUT0 1503.17FALSE00
2026-05-1520PUT0 0390.36FALSE00
2026-05-152.50.03PUT12 23189.77FALSE0.030
2026-05-1530.13PUT170 1019137.3FALSE0.060.86
2026-05-153.50.54PUT1 12208.52TRUE0.540
2026-05-1541.07PUT3 4342.89TRUE0.090.09
2026-05-154.51.48PUT8 3272.87TRUE0.050.04
2026-05-1551.94PUT5 1311.17TRUE0.040.02
2026-05-155.52.5PUT3 2426.07TRUE0.160.07
2026-05-1563.02PUT5 2513.06TRUE3.020
2026-05-156.53.47PUT1 1411.32TRUE3.470
2026-05-1573.98PUT1 1486.74TRUE3.980
2026-05-220.52.65CALL0 155855.56TRUE00
2026-05-2212.17CALL0 22904.74TRUE00
2026-05-221.51.7CALL0 181100.3TRUE00
2026-05-2221.13CALL0 14330.97TRUE00
2026-05-222.50CALL0 105149.17TRUE00
2026-05-2230.22CALL2 73115.26TRUE-0.08-0.27
2026-05-223.50.09CALL1 332130.83FALSE-0.03-0.25
2026-05-2240.05CALL0 72152.5FALSE00
2026-05-224.50CALL0 0527.55FALSE00
2026-05-2250CALL0 41544.58FALSE00
2026-05-225.50CALL0 1475.18FALSE00
2026-05-2260CALL0 2326.4FALSE00
2026-05-226.50CALL0 2641.08FALSE00
2026-05-220.50PUT0 0654.62FALSE00
2026-05-2210.05PUT0 3405.88FALSE00
2026-05-221.50PUT0 0267.47FALSE00
2026-05-2220.05PUT0 2634.38FALSE00
2026-05-222.50.03PUT0 6111.63FALSE00
2026-05-2230.13PUT0 1338.01FALSE00
2026-05-223.50.7PUT0 100TRUE00
2026-05-2241.15PUT0 19133.87TRUE00
2026-05-224.51.56PUT0 1170.23TRUE00
2026-05-2252.22PUT0 3615.69TRUE00
2026-05-225.52.46PUT0 4173.77TRUE00
2026-05-2263PUT2 40TRUE0.130.05
2026-05-226.50PUT0 1307.91TRUE00
2026-05-290.52.7CALL0 224728.37TRUE00
2026-05-2912.08CALL39 1270TRUE2.080
2026-05-291.51.55CALL0 4886.99TRUE00
2026-05-2921.05CALL0 5697.48TRUE00
2026-05-292.50.7CALL0 155149.29TRUE00
2026-05-2930.28CALL27 16124.71TRUE0.030.12
2026-05-293.50.13CALL0 661125.89FALSE00
2026-05-2940.06CALL0 170124.44FALSE00
2026-05-294.50CALL0 1201.8FALSE00
2026-05-2950CALL0 102229.62FALSE00
2026-05-295.50CALL0 41375.53FALSE00
2026-05-2960CALL0 0190.34FALSE00
2026-05-296.50CALL0 2504.25FALSE00
2026-05-2970CALL0 199513.33FALSE00
2026-05-290.50PUT0 0496.78FALSE00
2026-05-2910PUT0 0305.48FALSE00
2026-05-291.50PUT0 0198.84FALSE00
2026-05-2920.05PUT0 4567.25FALSE00
2026-05-292.50.1PUT0 16142.29FALSE00
2026-05-2930.28PUT0 1148.95FALSE00
2026-05-293.50.54PUT1 30TRUE0.540
2026-05-2941.03PUT0 30TRUE00
2026-05-294.51.5PUT1 10TRUE1.50
2026-05-2952.02PUT1 30TRUE0.080.04
2026-05-295.52.28PUT0 00TRUE00
2026-05-2960PUT0 1240.81TRUE00
2026-05-296.50PUT0 1508.83TRUE00
2026-05-2970PUT0 0275.49TRUE00
2026-06-050.52.35CALL282 4770TRUE-0.36-0.13
2026-06-0512.23CALL243 160587.41TRUE-0.07-0.03
2026-06-051.52CALL0 11665.8TRUE00
2026-06-0520CALL0 0612.24TRUE00
2026-06-052.50CALL0 0457.67TRUE00
2026-06-0530.33CALL0 25156.74TRUE00
2026-06-053.50.1CALL7 4812102.98FALSE-0.04-0.29
2026-06-0540.07CALL0 19124.99FALSE00
2026-06-054.50CALL0 0484.27FALSE00
2026-06-0550CALL0 0302.64FALSE00
2026-06-055.50CALL0 0325.22FALSE00
2026-06-0560CALL0 0344.96FALSE00
2026-06-056.50CALL0 0362.48FALSE00
2026-06-0570CALL0 0378.23FALSE00
2026-06-050.50PUT0 0413.62FALSE00
2026-06-0510.05PUT0 0252.17FALSE00
2026-06-051.50PUT0 0161.99FALSE00
2026-06-0520.1PUT1 8152.14FALSE0.099
2026-06-052.50PUT0 43489.52FALSE00
2026-06-0530.2PUT0 2777.13FALSE00
2026-06-053.50.42PUT0 3157.8TRUE00
2026-06-0540PUT0 00TRUE00
2026-06-054.50PUT0 0162.38TRUE00
2026-06-0550PUT0 0125.07TRUE00
2026-06-055.52.45PUT2 00TRUE2.450
2026-06-0562.92PUT4 10TRUE2.920
2026-06-056.53.5PUT0 10TRUE00
2026-06-0573.94PUT2 00TRUE3.940
2026-06-120.52.72CALL345 767897.23TRUE00
2026-06-1212.23CALL131 47545.35TRUE-0.07-0.03
2026-06-121.51.53CALL4 1320.78TRUE1.530
2026-06-1220CALL0 0236.83TRUE00
2026-06-122.50CALL0 0131.76TRUE00
2026-06-1230.4CALL1 2146.64TRUE0.40
2026-06-123.50.15CALL8 84114.94FALSE-0.04-0.21
2026-06-1240.05CALL4 4102.64FALSE0.050
2026-06-124.50CALL0 0469.92FALSE00
2026-06-1250CALL0 0157.56FALSE00
2026-06-125.50CALL0 0513.35FALSE00
2026-06-1260CALL0 0226.83FALSE00
2026-06-126.50CALL0 0546.83FALSE00
2026-06-120.50.07PUT0 1359.97FALSE00
2026-06-1210.15PUT0 1217.52FALSE00
2026-06-121.50PUT0 0137.76FALSE00
2026-06-1220PUT0 0252.64FALSE00
2026-06-122.50.1PUT0 4051.95FALSE00
2026-06-1230PUT0 067.6FALSE00
2026-06-123.50.47PUT0 60TRUE00
2026-06-1240PUT0 00TRUE00
2026-06-124.51.38PUT6 00TRUE1.380
2026-06-1250PUT0 00TRUE00
2026-06-125.52.45PUT3 00TRUE2.450
2026-06-1263.04PUT2 00TRUE3.040
2026-06-126.53.47PUT1 00TRUE3.470
2026-06-1812.09CALL40 18362.95TRUE-0.01-0
2026-06-1821.1CALL0 1020199.95TRUE00
2026-06-1830.3CALL31 1360140.59TRUE-0.05-0.14
2026-06-1840.1CALL40 4575120.58FALSE-0.02-0.17
2026-06-1850.05CALL69 5425134.32FALSE00
2026-06-1860.05CALL100 4266161.29FALSE0.050
2026-06-1870.05CALL0 2672160.77FALSE00
2026-06-1880CALL0 805339.64FALSE00
2026-06-1890CALL0 459273.83FALSE00
2026-06-18100.04CALL0 14681204.11FALSE00
2026-06-1810PUT0 1195.65FALSE00
2026-06-1820.05PUT0 19099.12FALSE00
2026-06-1830.25PUT0 75232.25FALSE00
2026-06-1841.05PUT12 15790TRUE-0.05-0.05
2026-06-1851.99PUT0 4140TRUE00
2026-06-1860PUT0 2760TRUE00
2026-06-1870PUT0 10TRUE00
2026-06-1880PUT0 20TRUE00
2026-06-1890PUT0 00TRUE00
2026-06-18107.1PUT0 00TRUE00
2026-06-260.52.71CALL263 572808.74TRUE2.710
2026-06-2610CALL0 0492.24TRUE00
2026-06-261.50CALL0 0547.43TRUE00
2026-06-2620CALL0 00TRUE00
2026-06-262.50CALL0 0178.17TRUE00
2026-06-2630.39CALL3 0132.04TRUE0.390
2026-06-263.50CALL0 0134.91FALSE00
2026-06-2640CALL0 0401.85FALSE00
2026-06-264.50CALL0 0207.32FALSE00
2026-06-2650.05CALL201 0126.46FALSE0.050
2026-06-265.50CALL0 0203.07FALSE00
2026-06-2660CALL0 0460.78FALSE00
2026-06-266.50CALL0 0473.82FALSE00
2026-06-260.50PUT0 00FALSE00
2026-06-2610PUT0 0713.67FALSE00
2026-06-261.50.05PUT0 1397.08FALSE00
2026-06-2620.05PUT0 2426.13FALSE00
2026-06-262.50PUT0 0114.35FALSE00
2026-06-2630.27PUT25 8136.33FALSE0.010.04
2026-06-263.50PUT0 00TRUE00
2026-06-2640PUT0 0142.74TRUE00
2026-06-264.50PUT0 00TRUE00
2026-06-2650PUT0 00TRUE00
2026-06-265.50PUT0 00TRUE00
2026-06-2660PUT0 0245.18TRUE00
2026-06-266.50PUT0 0257.92TRUE00
2026-09-1812.07CALL1 112678.84TRUE2.070
2026-09-1821.2CALL5 474196.4TRUE1.20
2026-09-1830.6CALL28 1944156.95TRUE-0.05-0.08
2026-09-1840.36CALL0 1269147.43FALSE00
2026-09-1850.2CALL28 4508145.42FALSE-0.05-0.2
2026-09-1860.15CALL9 1124149.84FALSE00
2026-09-1870.1CALL0 602147.55FALSE00
2026-09-1880.14CALL0 336180.95FALSE00
2026-09-1890.25CALL0 26298.13FALSE00
2026-09-18100.2CALL0 243164.46FALSE00
2026-09-1810.03PUT0 10117.43FALSE00
2026-09-1820PUT0 300FALSE00
2026-09-1830.48PUT0 1720FALSE00
2026-09-1841.08PUT0 3200TRUE00
2026-09-1850PUT0 1190TRUE00
2026-09-1860PUT0 180TRUE00
2026-09-1870PUT0 280TRUE00
2026-09-1880PUT0 00TRUE00
2026-09-1890PUT0 20TRUE00
2026-09-18100PUT0 00TRUE00
2026-12-1810CALL0 3328.38TRUE00
2026-12-1821.35CALL2 17230.03TRUE1.350
2026-12-1830.71CALL0 23205.3TRUE00
2026-12-1840.51CALL40 6172.43FALSE-0.07-0.12
2026-12-1850.42CALL1 748178.17FALSE-0.01-0.02
2026-12-1860CALL0 0161.03FALSE00
2026-12-1810PUT0 039.56FALSE00
2026-12-1820PUT0 700FALSE00
2026-12-1830PUT0 3450FALSE00
2026-12-1841.36PUT40 10TRUE1.360
2026-12-1850PUT0 00TRUE00
2026-12-1860PUT0 00TRUE00
2027-01-1512.1CALL7 200311.9TRUE2.10
2027-01-1521.45CALL0 4677261.05TRUE00
2027-01-1530.9CALL339 4173204.24TRUE-0.1-0.1
2027-01-1540.6CALL11 3919186.13FALSE-0.02-0.03
2027-01-1550.6CALL1 8531181.26FALSE0.60
2027-01-1560.4CALL0 209191.93FALSE00
2027-01-1570.35CALL0 5403189.49FALSE00
2027-01-15100.2CALL7 9483181.34FALSE-0.03-0.13
2027-01-15120.19CALL7 1385189.23FALSE0.030.19
2027-01-15150.3CALL1 1876226.02FALSE0.30
2027-01-15170.3CALL0 2838203.63FALSE00
2027-01-15200.07CALL10 16239177.28FALSE-0.03-0.3
2027-01-1510.05PUT0 7549.81FALSE00
2027-01-1520.26PUT0 3740FALSE00
2027-01-1530.74PUT0 7300FALSE00
2027-01-1540PUT0 13120TRUE00
2027-01-1552.23PUT0 11190TRUE00
2027-01-1560PUT0 00TRUE00
2027-01-1574.1PUT11 5890TRUE4.10
2027-01-15106.98PUT4 4690TRUE6.980
2027-01-15120PUT0 210TRUE00
2027-01-15150PUT0 10TRUE00
2027-01-15170PUT0 00TRUE00
2027-01-15200PUT0 00TRUE00
2028-01-2110CALL0 65574.37TRUE00
2028-01-2122.3CALL0 790TRUE00
2028-01-2131.5CALL3 3109320.02TRUE1.50
2028-01-2141.3CALL0 121285.01FALSE00
2028-01-2151.1CALL0 832269.21FALSE00
2028-01-2170.75CALL1 1782246.77FALSE0.070.1
2028-01-21100.45CALL0 7287226.65FALSE00
2028-01-2110.15PUT0 20FALSE00
2028-01-2120.55PUT1 00FALSE0.550
2028-01-2130PUT0 25363.5FALSE00
2028-01-2142.01PUT0 190TRUE00
2028-01-2150PUT0 430TRUE00
2028-01-2174.4PUT11 380TRUE4.40
2028-01-21107.13PUT4 410TRUE7.130

Latest ALT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$9.25
Jun 13, 2022 7:59 PM EST399$9.25
Jun 13, 2022 7:59 PM EST58$9.25
Jun 13, 2022 7:59 PM EST100$9.25
Jun 13, 2022 7:59 PM EST200$9.235

Altimmune, Inc (ALT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2019-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019007165/0000000000-19-007165-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012559/0000000000-19-012559-index.htm
2019-08-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012749/0000000000-19-012749-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319016650/0000899243-19-016650-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319017407/0000899243-19-017407-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2019-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023316/0000899243-19-023316-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023318/0000899243-19-023318-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319028409/0000899243-19-028409-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000074/0000899243-20-000074-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000275/0000899243-20-000275-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000276/0000899243-20-000276-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000279/0000899243-20-000279-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/0000899243-20-000286-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002630/0000899243-20-002630-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320006772/0000899243-20-006772-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320009897/0000899243-20-009897-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320011911/0000899243-20-011911-index.htm
2020-05-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012836/0000899243-20-012836-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012840/0000899243-20-012840-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320014937/0000899243-20-014937-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017823/0000899243-20-017823-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017824/0000899243-20-017824-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017826/0000899243-20-017826-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/0000899243-20-017831-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/0000899243-20-017833-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017835/0000899243-20-017835-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021020/0000899243-20-021020-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320023683/0000899243-20-023683-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026409/0000899243-20-026409-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/0000899243-20-026410-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026411/0000899243-20-026411-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026412/0000899243-20-026412-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026413/0000899243-20-026413-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026414/0000899243-20-026414-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/0000899243-20-026415-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026921/0000899243-20-026921-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/0000899243-20-028535-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/0000899243-20-028536-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028537/0000899243-20-028537-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028538/0000899243-20-028538-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028539/0000899243-20-028539-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028540/0000899243-20-028540-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320030113/0000899243-20-030113-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/0000925421-19-000135-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000137/0000925421-19-000137-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001065/0001012975-18-001065-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001091/0001012975-18-001091-index.htm
2018-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001271/0001012975-18-001271-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/0001012975-19-000028-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000029/0001012975-19-000029-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000031/0001012975-19-000031-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000033/0001012975-19-000033-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000035/0001012975-19-000035-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/0001012975-19-000037-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/0001012975-19-000039-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000041/0001012975-19-000041-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000043/0001012975-19-000043-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000106823820000055/0001068238-20-000055-index.htm
2018-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465918060692/0001104659-18-060692-index.htm
2019-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919005825/0001104659-19-005825-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919008563/0001104659-19-008563-index.htm
2020-06-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920068336/0001104659-20-068336-index.htm
2020-06-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1326190/000110465920076855/0001104659-20-076855-index.htm
2020-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920108310/0001104659-20-108310-index.htm
2020-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920112175/0001104659-20-112175-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518280602/0001193125-18-280602-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518280966/0001193125-18-280966-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518281668/0001193125-18-281668-index.htm
2018-09-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/0001193125-18-284095-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285764/0001193125-18-285764-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285783/0001193125-18-285783-index.htm
2018-09-28POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518286447/0001193125-18-286447-index.htm
2018-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518289729/0001193125-18-289729-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518289763/0001193125-18-289763-index.htm
2018-10-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518293265/0001193125-18-293265-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518295412/0001193125-18-295412-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518295424/0001193125-18-295424-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518296082/0001193125-18-296082-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518304261/0001193125-18-304261-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518325584/0001193125-18-325584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518325587/0001193125-18-325587-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518335258/0001193125-18-335258-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339667/0001193125-18-339667-index.htm
2018-11-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339756/0001193125-18-339756-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518340078/0001193125-18-340078-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519033928/0001193125-19-033928-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519067835/0001193125-19-067835-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519070141/0001193125-19-070141-index.htm
2019-03-11424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1326190/000119312519070146/0001193125-19-070146-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519076851/0001193125-19-076851-index.htm
2019-04-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519097986/0001193125-19-097986-index.htm
2019-04-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312519097996/0001193125-19-097996-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519103831/0001193125-19-103831-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519104131/0001193125-19-104131-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519168149/0001193125-19-168149-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519171212/0001193125-19-171212-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519178904/0001193125-19-178904-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519190926/0001193125-19-190926-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519193586/0001193125-19-193586-index.htm
2019-08-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519218069/0001193125-19-218069-index.htm
2019-08-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519221188/0001193125-19-221188-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224352/0001193125-19-224352-index.htm
2019-08-19PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224357/0001193125-19-224357-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519225595/0001193125-19-225595-index.htm
2019-08-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519226618/0001193125-19-226618-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519259847/0001193125-19-259847-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520087649/0001193125-20-087649-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520088680/0001193125-20-088680-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520100902/0001193125-20-100902-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520139801/0001193125-20-139801-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520156447/0001193125-20-156447-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520156472/0001193125-20-156472-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520191485/0001193125-20-191485-index.htm
2020-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520191866/0001193125-20-191866-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520192791/0001193125-20-192791-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194024/0001193125-20-194024-index.htm
2020-07-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194052/0001193125-20-194052-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226963/0001193125-20-226963-index.htm
2020-08-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226971/0001193125-20-226971-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520254566/0001193125-20-254566-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000120919120009672/0001209191-20-009672-index.htm
2018-10-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390018014006/0001213900-18-014006-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390019001904/0001213900-19-001904-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390020003212/0001213900-20-003212-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382519000035/0001393825-19-000035-index.htm
2020-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382520000012/0001393825-20-000012-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459019010429/0001564590-19-010429-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019010435/0001564590-19-010435-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019019139/0001564590-19-019139-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019019146/0001564590-19-019146-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019031795/0001564590-19-031795-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019031811/0001564590-19-031811-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019043231/0001564590-19-043231-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019043240/0001564590-19-043240-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020013376/0001564590-20-013376-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459020013377/0001564590-20-013377-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020025123/0001564590-20-025123-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020025137/0001564590-20-025137-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020039298/0001564590-20-039298-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020039314/0001564590-20-039314-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000001/0001738048-20-000001-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2018-09-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999518002478/9999999995-18-002478-index.htm
2019-04-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999519000701/9999999995-19-000701-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1326190/999999999718008376/9999999997-18-008376-index.htm

Altimmune, Inc (ALT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc (ALT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 651%
Institutional Ownership: 6730%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-31William Michael BrownChief Financial OfficerBuy7,920.001.4611,563.2015,981.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-05-15VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell30,622.004.65142,392.301,687,250.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-05-14VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell169,378.004.81814,708.181,717,872.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2018-10-09Wayne PisanoDirectorBuy2,000.004.599,180.002,000.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy309,453.008.792,720,091.872,005,817.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy390,547.009.783,819,549.662,396,364.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy125,162.007.23904,921.262,521,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy277,000.007.922,193,840.002,798,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy27,763.007.79216,273.772,826,289.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy173,711.008.871,540,816.573,000,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2018-11-30Vipin K GargPresident and CEOBuy322,907.00322,907.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2020-07-31Vipin K GargChief Financial OfficerBuy11,674.001.4617,044.04325,789.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-01-31Vipin K GargPresident and CEOBuy11,289.001.4616,481.94326,206.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2019-09-05Vipin K GargPresident and CEOBuy20,000.002.1042,000.00342,907.00https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2020-06-15Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy1,500,000.007.5411,310,000.004,500,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2020-01-31M Scot RobertsChief Scientific OfficerBuy3,698.001.465,399.085,535.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-01-31William Michael BrownChief Financial OfficerBuy8,061.001.4611,769.068,061.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-07-31Matthew Scott HarrisChief Medical OfficerBuy8,084.001.4611,802.648,084.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-07-31M Scot RobertsChief Scientific OfficerBuy3,859.001.465,634.149,394.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm